Aatmaj Healthcare
- P/E
- 2.75
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of · TTM
- ROCE
- 3.60%
- Debt to Equity
- 0.41
- EPS (TTM)
- ₹8.20
- Book Value
- ₹22.49
- Market Cap
- —
- P/E (TTM)
- 2.75
- P/B
- 1.00
- ROE
- 1.43%
- Dividend Yield
- 0.22%
- EBITDA
- ₹3.30 Cr
- 52W High
- ₹25.50
- 52W Low
- ₹16.70
- Volume
- 0
Peer Comparison
Healthcare › Healthcare Services › Hospitals › Hospital
| ₹8,599.50 | 59.18 | ₹1,22,850 Cr | 13.04 | 0.24% | 21.20% | 17.40% | ₹26,430 Cr | ₹2,171 Cr | |
| ₹927.15 | 61.89 | ₹89,301 Cr | 7.96 | 0.22% | 14.70% | 14.70% | ₹8,712 Cr | ₹1,457 Cr | |
| ₹667.20 | 88.96 | ₹86,479 Cr | 5.34 | 0.00% | 6.64% | 8.30% | ₹11,400 Cr | ₹906 Cr | |
| ₹719.55 | 117.00 | ₹59,927 Cr | 14.91 | 0.44% | 11.30% | 11.60% | ₹4,876 Cr | ₹363 Cr | |
| ₹790.65 | 56.96 | ₹59,706 Cr | 6.03 | 0.13% | 11.20% | 13.40% | ₹9,506 Cr | ₹1,070 Cr | |
| ₹1,931.50 | 48.36 | ₹39,090 Cr | 7.89 | 0.24% | 20.50% | 15.50% | ₹9,072 Cr | ₹816 Cr | |
| ₹1,402.00 | 67.76 | ₹37,618 Cr | 9.52 | 0.04% | 15.20% | 17.40% | ₹4,683 Cr | ₹552 Cr | |
| ₹22.55 | 2.75 | ₹52 Cr | 1.00 | 0.22% | 1.43% | 3.60% | ₹36 Cr | ₹8 Cr | |
| Median 8 companies | ₹858.90 | 60.54 | ₹59,817 Cr | 7.93 | 0.22% | 13.00% | 14.05% | ₹8,892 Cr | ₹861 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 64
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 69
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 63
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 49
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 80
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 53
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.98 times its book value
Weaknesses
6- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.78% over past five years.
- Company has a low return on equity of 1.70% over last 3 years.
- Earnings include an other income of Rs.0.93 Cr.
- Company has high debtors of 398 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 4 | 7 | 8 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bullish | 3 | 0 | 7 |
Oscillators
Neutral
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 53.73
- Neutral
- MACD (12,26,9)
- 0.64
- Bearish
- SMA (50)
- 20.45
- Bullish
- SMA (200)
- 20.68
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +7.78% |
|---|---|
| 3Y | −1.73% |
| 1Y | +17.53% |
Net profit
| 5Y | −29.65% |
|---|---|
| 3Y | −50.66% |
| 1Y | +10.94% |
Operating cash flow
| 5Y | +2.96% |
|---|---|
| 3Y | +9.87% |
| 1Y | +111.68% |
Operating margin· change in pp
| 5Y | −23.50 pp |
|---|---|
| 3Y | −30.76 pp |
| 1Y | +2.56 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹4.13 Cr |
|---|---|
| Mar 2021 | ₹15.49 Cr |
| Mar 2022 | ₹20.26 Cr |
| Mar 2023 | ₹23.74 Cr |
| Mar 2024 | ₹14.84 Cr |
| Mar 2025 | ₹19.17 Cr |
| Mar 2026 | ₹22.53 Cr |
Net profit by year
| Mar 2020 | −₹0.27 Cr |
|---|---|
| Mar 2021 | ₹4.12 Cr |
| Mar 2022 | ₹5.05 Cr |
| Mar 2023 | ₹5.91 Cr |
| Mar 2024 | ₹0.88 Cr |
| Mar 2025 | ₹0.64 Cr |
| Mar 2026 | ₹0.71 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 13.42 | 13.74 | 8.57 | 7.17 | 8.51 | 11.03 | 10.81 | 13.51 |
| Expenses | 8.84 | 8.49 | 4.7 | 8.49 | 8.1 | 9.89 | 9.48 | 12.49 |
| Operating Profit | 4.58 | 5.25 | 3.87 | −1.32 | 0.41 | 1.14 | 1.33 | 1.02 |
| OPM % | 34.13% | 38.21% | 45.16% | −18.41% | 4.82% | 10.34% | 12.3% | 7.55% |
| Other Income | 0.03 | 0 | 0.24 | 0.61 | 0.76 | 0.56 | 0.44 | 0.52 |
| Interest | 0.25 | 0.65 | 0.59 | 0.66 | 0.37 | 0.51 | 0.57 | 0.8 |
| Depreciation | 0.34 | 0.34 | 0.38 | 0.43 | 0.47 | 0.45 | 0.51 | 0.46 |
| PBT | 4.02 | 4.26 | 3.14 | −1.8 | 0.33 | 0.74 | 0.69 | 0.28 |
| Tax % | 27.61% | 29.34% | 27.39% | −22.22% | 6.06% | 55.41% | 26.09% | 28.57% |
| Net Profit | 2.9 | 3.01 | 2.29 | −1.41 | 0.31 | 0.33 | 0.51 | 0.2 |
| EPS (₹) | 1.79 | 1.86 | 1.01 | −0.62 | 0.14 | 0.15 | 0.23 | 0.09 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 4.13 | 15.49 | 20.26 | 23.74 | 14.84 | 19.17 | 22.53 |
| Expenses | 3.46 | 10.2 | 12.75 | 13.91 | 12.29 | 17.62 | 20.13 |
| Operating Profit | 0.67 | 5.29 | 7.51 | 9.83 | 2.55 | 1.55 | 2.4 |
| OPM % | 16.22% | 34.15% | 37.07% | 41.41% | 17.18% | 8.09% | 10.65% |
| Other Income | 0.01 | 0 | 0 | 0.03 | 0.85 | 1.32 | 0.93 |
| Interest | 0.5 | 0.44 | 0.24 | 0.9 | 1.25 | 0.88 | 1.38 |
| Depreciation | 0.36 | 0.39 | 0.43 | 0.69 | 0.81 | 0.92 | 0.97 |
| PBT | −0.18 | 4.46 | 6.84 | 8.27 | 1.34 | 1.07 | 0.98 |
| Tax % | 50% | 7.4% | 26.02% | 28.66% | 34.33% | 40.19% | 26.53% |
| Net Profit | −0.27 | 4.12 | 5.05 | 5.91 | 0.88 | 0.64 | 0.71 |
| EPS (₹) | −0.17 | 2.54 | 3.12 | 3.65 | 0.39 | 0.28 | 0.31 |
| Div. Payout % | 0% | 0% | 0% | 0% | 12.84% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1.35 | 1.35 | 1.35 | 8.1 | 11.3 | 11.3 | 11.3 |
| Reserves | −2.28 | 1.84 | 6.92 | 6.08 | 38.18 | 38.82 | 39.53 |
| Borrowings | 8.76 | 4.33 | 5.18 | 11.69 | 5.47 | 10.06 | 21.03 |
| Other Liabilities | 1.5 | 2.28 | 4.03 | 5.14 | 2.73 | 3.07 | 4.79 |
| Total Liabilities | 9.33 | 9.8 | 17.48 | 31.01 | 57.68 | 63.25 | 76.65 |
| Fixed Assets | 8.02 | 8.21 | 10.87 | 11.17 | 18.18 | 18 | 29.46 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0.53 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.31 | 1.59 | 6.61 | 19.84 | 39.5 | 45.25 | 46.66 |
| Total Assets | 9.33 | 9.8 | 17.48 | 31.01 | 57.68 | 63.25 | 76.65 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | −0.54 | 6.11 | 9.55 | 5.33 | −8.01 | 3.34 | 7.07 |
| Investing | −0.18 | −0.71 | −3.37 | −1.42 | −7.82 | −0.69 | −12.38 |
| Financing | 0.67 | −4.87 | −6.55 | −3.78 | 26.32 | −1.29 | 4.85 |
| Net Cash Flow | −0.05 | 0.53 | −0.37 | 0.14 | 10.49 | 1.35 | −0.47 |
| Free Cash Flow | −0.72 | 5.54 | 6.45 | 4.35 | −15.83 | 2.6 | −5.32 |
| CFO/EBITDA | −81 | 120 | 104 | 32 | −327 | 215 | 295 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 86.61 | 13.43 | 91.88 | 274 | 507 | 468 | 398 |
| Inventory Days | 64.68 | 18.38 | — | — | — | — | — |
| Days Payable | 494 | 149 | — | — | — | — | — |
| Cash Conversion Cycle | −343 | −117 | 91.88 | 274 | 507 | 468 | 398 |
| Working Capital Days | −166 | −46.18 | −28.1 | 79.18 | 555 | 427 | 306 |
| ROCE % | — | 63.84% | 67.53% | 46.64% | 6.41% | 3.39% | 3.6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aatmaj Healthcare insights
56 extracted metrics across FY20–FY26.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Concall · Nov 2023Transcript PPT
- 13 Oct 2026
- 13 Oct 2026
- 13 Oct 2026
Frequently Asked Questions about Aatmaj Healthcare
What does Aatmaj Healthcare Ltd do?
Where is Aatmaj Healthcare Ltd (AATMAJ) listed?
Which sector does Aatmaj Healthcare Ltd belong to?
What is the PE ratio of Aatmaj Healthcare Ltd?
What is the 52-week high and low of Aatmaj Healthcare Ltd?
Does Aatmaj Healthcare Ltd pay dividends?
What is the Return on Equity (ROE) of Aatmaj Healthcare Ltd?
Company Information
Incorporated in 2022, Aatmaj Healthcare Ltd provides multi-speciality and super-specially healthcare services
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AATMAJ.md for Aatmaj Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.